Delivery Order SPE2DB22D3301-SPE2DB26FX3RK
- Not listed
- The Defense Logistics Agency awarded a $1,768.44 delivery order to AmerisourceBergen Drug Corp for XCOPRI 50 mg tablets (30-count supply) under a firm fixed price contract type. The award was issued on June 2, 2025, with an ultimate completion date of June 3, 2025, and represents a non-set-aside competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, performed the work at its corporate office location. This delivery order is a child contract under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for XCOPRI 100 mg tablets (30-count) on May 20, 2025, with a ceiling value of $1,979.46 under a firm fixed-price contract type. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The award was made through open competition with no set-aside designation,...
- The Defense Logistics Agency awarded a delivery order valued at $1,102.21 to AmerisourceBergen Drug Corp for XCOPRI 50-100 mg Titration Pak (28 count) on July 30, 2025, with an ultimate completion date of July 31, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. XCOPRI (cenobamate) is an anticonvulsant medication used to treat seizure disorders, and this delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,178.96 to AmerisourceBergen Drug Corp for XCOPRI 25 mg tablets (30-count package). The contract, issued on September 8, 2025, with an ultimate completion date of September 9, 2025, represents a firm fixed-price delivery order with no set-aside designation. The work will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,874.46 to AmerisourceBergen Drug Corp for XCOPRI 50 mg tablets (30-count supply) under a firm fixed-price contract. The award was made on September 17, 2025, with an ultimate completion date of September 18, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a $3,536.88 delivery order to AmerisourceBergen Drug Corp for XCOPRI 25 mg tablets (30-count units) with a firm fixed price structure. The contract, which was competitively awarded without set-aside designation, is scheduled for completion by June 2, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for XCOPRI 200 mg tablets (30-count packaging) under a firm fixed-price contract valued at $1,768.44, with an ultimate completion date of August 20, 2025. This non-set-aside, competitively awarded delivery order was issued on August 19, 2025, and will be performed at the vendor's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for XCOPRI 100 mg tablets (30-count) valued at $3,536.88 under a firm fixed-price contract type. The award was made on September 19, 2025, with an ultimate completion date of September 22, 2025, and represents a non-competitive delivery order issued without a set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for XCOPRI 150 mg tablets (30-count) on June 24, 2025, with a ceiling value of $1,239.53 and firm fixed pricing. This non-competitive delivery order is expected to complete by June 25, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. XCOPRI (cenobamate) is a prescription anti-seizure medication used in the treatment of focal seizures, reflecting the Defense...
- The Defense Logistics Agency awarded a delivery order valued at $3,937.76 to AmerisourceBergen Drug Corp for XCOPRI 25 mg tablets (30-count supply) with a firm fixed price structure. The award, issued on September 10, 2025, with an ultimate completion date of September 11, 2025, represents a non-competitive, non-set-aside procurement. Performance will take place at the contractor's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's $999.9...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB26FX3RKDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,768.44 to AmerisourceBergen Drug Corp for XCOPRI 200 MG tablets (30-count) on October 22, 2025, with completion targeted for October 23, 2025. This competitively awarded, firm fixed-price contract involves performance at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. As a non-set-aside award, this delivery order was competed among qualified pharmaceutical distributors to support federal medical procurement requirements. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. This comprehensive prime vendor contract enables AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare systems globally. XCOPRI (cenobamate), a seizure medication, exemplifies the specialized pharmaceutical commodities delivered through this vehicle to support Defense Health Agency and other federal healthcare customers. The company's consistent performance across multiple competitive awards demonstrates its capability to fulfill diverse federal medical supply requirements with flexible delivery terms and fixed pricing.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 10/22/25 |